Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_assertion wasGeneratedBy ECO_0000203 NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_assertion wasDerivedFrom befree-20150227 NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_assertion SIO_000772 22303460 NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_assertion evidence source_evidence_literature NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.
- NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_assertion description "[Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492016.RAc2DQbAp62veF2x5DN-tS_nMSPxuGzDM_HY6Zu1Rr6mw130_provenance.